Calcitonin Gene Related Peptide Type 1 Receptor Market

Calcitonin Gene Related Peptide Type 1 Receptor Market contains market size and forecasts of Calcitonin Gene Related Peptide Type 1 Receptor in global, including the following market information:
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Calcitonin Gene Related Peptide Type 1 Receptor companies in 2021 (%)
The global Calcitonin Gene Related Peptide Type 1 Receptor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
AFAP-3 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Calcitonin Gene Related Peptide Type 1 Receptor include Allergan Plc, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Eli Lilly and Company, Fortress Biotech Inc, Merck & Co Inc, Teva Pharmaceutical Industries Ltd and Vertex Pharmaceuticals Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Calcitonin Gene Related Peptide Type 1 Receptor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Calcitonin Gene Related Peptide Type 1 Receptor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Segment Percentages, by Type, 2021 (%)
AFAP-3
AGN-241689
CGRP
Erenumab
Others
Global Calcitonin Gene Related Peptide Type 1 Receptor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Segment Percentages, by Application, 2021 (%)
Cardiovascular
Metabolic Disorders
Dental Pain
Others
Global Calcitonin Gene Related Peptide Type 1 Receptor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Calcitonin Gene Related Peptide Type 1 Receptor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Calcitonin Gene Related Peptide Type 1 Receptor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Calcitonin Gene Related Peptide Type 1 Receptor revenues share in global market, 2021 (%)
Key companies Calcitonin Gene Related Peptide Type 1 Receptor sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Calcitonin Gene Related Peptide Type 1 Receptor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan Plc
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Eli Lilly and Company
Fortress Biotech Inc
Merck & Co Inc
Teva Pharmaceutical Industries Ltd
Vertex Pharmaceuticals Inc